Volume 29, Issue 1 (Monthly_Apr 2018)
Studies in Medical Sciences 2018, 29(1): 50-62 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rezaeian Marjani L, Imani M, Zarei Jalian H. ENGINEERING OF THERAPEUTIC ASPERGILLUS FLAVUS URICASE USING SITE-DIRECTED MUTAGENESIS. Studies in Medical Sciences 2018; 29 (1) :50-62
URL: http://umj.umsu.ac.ir/article-1-4284-en.html
URL: http://umj.umsu.ac.ir/article-1-4284-en.html
Department of Basic Sciences, School of Veterinary Medicine, Urmia University, Urmia, Iran , m.imani@urmia.ac.ir
Abstract: (5135 Views)
Background & Aims: As a therapeutic enzyme, Aspergillus flavus (uricase or; EC 1.7.3.3), is used for treatment of urate deposits, gout and nephropathy, hyperuricemia and tumor lysis syndrom (TLS). Despite desirable kinetic features, fragile stability of uricase limits its wide range applications. Therefore, several approaches have developed such as protein engineering and genetic manipulations to overcome these problems. The main aim of the current research was the design and creation of disulfide bridge in therapeutic enzyme uricase for the first time.
Materials & Methods: By the help of bioinformatics studies and based on protein data bank (PDB) code: 1xxj, the potential points for disulfide bridge formation were selected. To create mutations, site-directed mutagenesis using SOE-PCR was employed.
Results: According to computational tools, six potential pairs including three intra and three inter-chains were predicted to form disulfide when mutated to cysteins as followings: Ser145-Thr185, Ala235-Val248, His256-Gln281 and Ala6-Cys290, Ser282–Ser282, Asn12-Asp283. By means of SOE-PCR, mutation and cloning of Ala6 and Ser282 was implemented and verified by colony PCR, digestion check and eventually by sequencing.
Conclusion: In the current research, we successfully determined the location for mutating to cystein and fortunately implemented mutagenesis by SOE-PCR.
Materials & Methods: By the help of bioinformatics studies and based on protein data bank (PDB) code: 1xxj, the potential points for disulfide bridge formation were selected. To create mutations, site-directed mutagenesis using SOE-PCR was employed.
Results: According to computational tools, six potential pairs including three intra and three inter-chains were predicted to form disulfide when mutated to cysteins as followings: Ser145-Thr185, Ala235-Val248, His256-Gln281 and Ala6-Cys290, Ser282–Ser282, Asn12-Asp283. By means of SOE-PCR, mutation and cloning of Ala6 and Ser282 was implemented and verified by colony PCR, digestion check and eventually by sequencing.
Conclusion: In the current research, we successfully determined the location for mutating to cystein and fortunately implemented mutagenesis by SOE-PCR.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
